Over the last 30 years, evidence has been gathered suggesting that merozoite surface
protein 1 (MSP1) is a target of protective immunity against malaria. In a variety of …

The parasitic ciliate Ichthyophthirius multifiliis (Ich), which infects almost all freshwater fish
species, provides an optimal model for the study of immunity against extracellular protozoa …

In the year 2003 there was a 17% increase in the number of publications citing work
performed using optical biosensor technology compared with the previous year. We collated …

The success of passive immunization suggests that antibody-based therapies will be
effective at controlling malaria. We describe the development of fully human antibodies …

Repeated infections by Plasmodium falciparum result in a humoral response that could
reduce disease symptoms and prevent the development of clinical malaria. The principal …

Background Naturally-acquired immunity to Plasmodium falciparum malaria develops after
several episodes of infection. Fc gamma receptors (FcγRs) bind to immunoglobulin G (IgG) …

Malaria, caused by Plasmodium parasite infection, continues to be one of the leading
causes of worldwide morbidity and mortality. Development of an effective vaccine has been …

Global eradication of the human-infecting malaria parasite Plasmodium falciparum, the
major cause of malaria mortality, is unlikely to be achieved without an effective vaccine …

A decreased susceptibility of Fulani populations to malaria infections has been shown in
Africa. A previous longitudinal cohort study conducted in the Atacora region of northern …

Background Identification of plasmodial antigens targeted by protective immune
mechanisms is important for malaria vaccine development. Among functional assays, the …